Lululemon Athletica’s Q4 guidance edges up but low end of range could fall a penny short of FactSet consensus estimate

Company boosts outlook but may slightly miss Wall Street’s earnings mark.

Previous post Moderna’s stock rises on 2023 product sales of $6.7B
Next post Uh-oh: Everyone is back to buying stocks again.